Issue 36, 2023

Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies

Abstract

Immunotherapy is a new type of tumor treatment after surgery, radiotherapy and chemotherapy, and can be used to manage and destroy tumor cells through activating or strengthening the immune response. Immunotherapy has the benefits of a low recurrence rate and high specificity compared to traditional treatment methods. Immunotherapy has developed rapidly in recent years and has become a research hotspot. Currently, chimeric antigen receptor T-cell immunotherapy and immune checkpoint inhibitors are the most effective tumor immunotherapies in clinical practice. While tumor immunotherapy brings hope to patients, it also faces some challenges and still requires continuous research and progress. Combination therapy is the future direction of anti-tumor treatment. In this review, the main focus is on an overview of the research progress of immune checkpoint inhibitors, cellular therapies, tumor vaccines, small molecule inhibitors and oncolytic virotherapy in tumor treatment, as well as the combination of immunotherapy with other treatments.

Graphical abstract: Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies

Article information

Article type
Review Article
Submitted
14 6 2023
Accepted
08 8 2023
First published
11 8 2023

J. Mater. Chem. B, 2023,11, 8586-8604

Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies

Y. Guo, F. Gao, A. Ahmed, M. Rafiq, B. Yu, H. Cong and Y. Shen, J. Mater. Chem. B, 2023, 11, 8586 DOI: 10.1039/D3TB01358H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements